Abstract
To the Editor: I read with great interest the article regarding lymphocytic choriomeningitis virus (LCMV) meningitis in a New York City resident (1). The authors’ conclusion that there is a need to ascertain the true incidence of LCMV infection is worthy of underscoring. Nearly 15 years ago, in this same journal, we described congenital LCMV as an unrecognized teratogen and recommended further “research to define the frequency of LCMV” (2). Five years later, we reiterated that recommendation when reporting acquired LCMV meningoencephalitis in an adolescent from Tucson, Arizona (3). Despite, or because of, the lack of prospective studies, the fact that this author has accrued data regarding >60 congenitally infected infants from all geographic areas in the United States during the past 15 years reinforces the concept that LCMV is a neglected pathogen whose time for more extensive study has indeed come.
Highlights
To the Editor: I read with great interest the article regarding lymphocytic choriomeningitis virus (LCMV) meningitis in a New York City resident (1)
15 years ago, in this same journal, we described congenital LCMV as an unrecognized teratogen and recommended further “research to define the frequency of LCMV” (2)
To the Editor: Lai et al (1) reported an increase in the number of nontuberculous mycobacteria (NTM) isolates and patients with pulmonary NTM diseases after implementation of the BACTEC system (Becton Dickinson, Sparks, MD, USA) late in 2001. These authors reported that the increase was mainly in persons infected with Mycobacterium avium complex (MAC) and M. abscessus
Summary
Author affiliations: Western Galilee Hospital, Nahariya, Israel 1. Oseltamivir-resistant 2009 pandemic influenza (H1N1) virus infection in two summer campers receiving prophylaxis— North Carolina, 2009. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients—Seattle, Washington, 2009. 4. Glikman D, Zonis Z, Hindiyeh M, Ram D, Mandelboim M, Mendelson E, et al Development of oseltamivir resistance during oseltamivir therapy in child with severe 2009 H1N1 influenza.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
